CIK 0001982708 · Non-accelerated filer<br>Emerging growth company
Anbio Biotechnology
Sign in to watch- Ticker
- NNNN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 4916096247281
- Business address
- FRIEDRICH-EBERT-ANLAGE 49, FRANKFURT AM MAIN, Germany, 60308
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 20-F/A Report Annual and Transition Report of Foreign Private Issuers
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- F-1/A Offering Registration Statement for Certain Foreign Private Issuers
- F-1/A Offering Registration Statement for Certain Foreign Private Issuers
- F-1/A Offering Registration Statement for Certain Foreign Private Issuers
- F-1 Offering Registration Statement for Certain Foreign Private Issuers
Page 1 of 1 · 14 filings